Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Kiromic Biopharma, Inc. (KRBP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/13/2022 |
8-K
| Quarterly results |
| 04/08/2022 |
8-K
| Quarterly results |
| 03/11/2022 |
8-K
| Quarterly results|
Docs:
|
"Quarter Updates Include Company’s Progress in the Following Areas: Expansion of DIAMOND ® AI Platform to More than 1.5 Billion Data Points Completion of InSilico Solutions, LLC Acquisition Closing of Public Offering Addition of Key Personnel Across Bioinformatics, Clinical Translational, Manufacturing, and Operations HOUSTON, March 11, 2022 – Kiromic BioPharma, Inc. , a clinical-stage fully integrated biotherapeutics company using its proprietary DIAMOND ® artificial intelligence and big data mining platform to discover and develop cell and gene therapies with a therapeutic focus on immuno-oncology and other diseases, today reported business updates and financial results for its third quarter ending September 30, 2021. “We believe that we made meaningful progress during the third quarter o..." |
|
| 08/13/2021 |
8-K
| Quarterly results |
| 05/14/2021 |
8-K
| Quarterly results |
| 03/31/2021 |
8-K
| Quarterly results |
| 11/30/2020 |
8-K
| Quarterly results |
|
|